USA – US-based baby nutrition company, ByHeart, officially announced the FDA registration of the Pennsylvania manufacturing facility, becoming only the 4th vertically integrated U.S. infant formula brand to have full oversight of its production, supply chain, and R&D.
ByHeart’s registration strengthens the fragile U.S. infant nutrition supply chain and seeks to mitigate the risk of formula shortages, with retail stores across the US reaching nearly 30% out of stock inventory on infant formula last month.
The company has confirmed it is not experiencing a shortage of baby formula despite a looming scarcity of the product in the market since its start of commercializing its products.
The shortage can be traced back to after Abbott voluntarily shut down the factory in February, amid consumer complaints about the contaminated formula that was linked to two infant deaths.
Abbot factory’s prolonged shutdown, combined with general supply-chain problems for the formula ingredients and packaging, has led to formula stock drying up fast.
Baby infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible.
ByHeart launched its groundbreaking Infant Formula in March after, becoming the only new infant formula brand in decades to rewrite the recipe from scratch.
The baby nutrition company says they realized that there have been significant modern advancements in nutrition science and breast milk research, which had not been incorporated into the infant formulas currently on the market.
The company decided to re-engineer the formula in order to acquire their own manufacturing and R&D, source every ingredient, and apply rigorous quality standards, from farm to formula.
Additionally, ByHeart says it spent five years working on breast milk research to develop the first infant formula in the US to include a patented protein blend that is closest to breast milk.
They suggest that the infant formula is organic and contains grass-fed whole milk as opposed to skim, used by most other formulas.
Furthermore, ByHeart claims to have been able to include lactoferrin and breast milk levels of alpha-lactalbumin (the two most abundant proteins in breast milk), as well as broken down proteins and an 80:20 whey to casein ratio that most closely mirrors colostrum or early breast milk into the formula.
Allied Market Research projects the market size of baby infant formula to reach $5,811 million by 2027 registering a CAGR of 5.8% from 2021 to 2027.
The changing lifestyle of the middle-class population due to rapid urbanization and rising disposable is boosting the U.S and also Increasing participation of women in the labor force in the U.S.
Owing to health concerns, baby infant formula free from ingredients such as added sugar, sodium, and preservatives is expected to present new opportunities for manufacturers in the U.S. baby infant formula market.
Liked this article? Subscribe to Food Business Africa News, our regular email newsletters with the latest news insights from Africa and the World’s food and agro industry. SUBSCRIBE HERE